跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACETAMINOPHEN 325 MG - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACETAMINOPHEN 325 MG
Authorized
STANDARD
ACETAMINOPHEN 325 MG
cellchem pharmaceuticals inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
57a571ff05775d4f
Company
cellchem pharmaceuticals inc.
Type
Standard
Approval Details
Approval Id
57a571ff05775d4f
Drug Approval Canada Name
ACETAMINOPHEN 325 MG
Product Name
ACETAMINOPHEN 325 MG
Status
Dormant
Status Date
2020-07-30
Original Market Date
2016-09-06
Din
02447479
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
OTC
Ahfs
28:08.92
Atc Original
N02BE01 ACETAMINOPHEN (PARACETAMOL)
Atc Name
n 02 be 01
Aig Number
0102009001
Company Name
cellchem pharmaceuticals inc.
Company Address
UNIT 1, 30 Concourse Gate, Ottawa, Ontario, Canada, K2E 7V7
Active Ingredients
ACETAMINOPHEN
325 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
57a571ff05775d4f
Type
Standard
Back to Health Canada Approvals